Cite
Early Start Of Tenofovir Treatment Achieves Better Viral Suppression In Pregnant Women With A High HBV Viral Load: A Real-World Prospective Study
MLA
Wei-Min Wang, et al. “Early Start Of Tenofovir Treatment Achieves Better Viral Suppression In Pregnant Women With A High HBV Viral Load: A Real-World Prospective Study.” Infection and Drug Resistance, Nov. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2d2f687e65645c3dd13d9f6eeec5b58d&authtype=sso&custid=ns315887.
APA
Wei-Min Wang, Na Xu, Fan Gao, Guiqin Bai, Wen-Tao Zhang, & Ya-Yun Lin. (2019). Early Start Of Tenofovir Treatment Achieves Better Viral Suppression In Pregnant Women With A High HBV Viral Load: A Real-World Prospective Study. Infection and Drug Resistance.
Chicago
Wei-Min Wang, Na Xu, Fan Gao, Guiqin Bai, Wen-Tao Zhang, and Ya-Yun Lin. 2019. “Early Start Of Tenofovir Treatment Achieves Better Viral Suppression In Pregnant Women With A High HBV Viral Load: A Real-World Prospective Study.” Infection and Drug Resistance, November. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....2d2f687e65645c3dd13d9f6eeec5b58d&authtype=sso&custid=ns315887.